The University of Rochester is partnering with Optel, Inc., to develop and build commercial clinical prototypes to characterize and assist in the management of dry eye disease (DED). These prototypes are based on a proprietary laboratory instrument developed at the University of Rochester, The Institute of Optics and Flaum Eye Institute that has been shown to characterize dye eye and the effect of several types of eye drops. DED affects an estimated 40 million individuals in the U.S. and given its predisposition and increased prevalence with age, along with its association with cataract and refractive surgery, incidence is predicted to increase with the aging population and increased use of digital displays that alters blink behavior.